Literature DB >> 9756801

Is the FDA approving drugs too fast?. Probably not--but drug recalls have sparked debate.

J D Kleinke, S Gottlieb.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9756801      PMCID： PMC1113977          DOI： 10.1136/bmj.317.7163.899

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Approval of new drugs in the United States. Comparison with the United Kingdom, Germany, and Japan.

Authors:  D A Kessler; A E Hass; K L Feiden; M Lumpkin; R Temple
Journal:  JAMA       Date:  1996-12-11       Impact factor: 56.272
  1 in total
  2 in total

1.  FDA approves drugs even when experts on its advisory panels raise safety questions.

Authors:  L Landow
Journal:  BMJ       Date:  1999-04-03

Review 2.  Lessons for clinical trials from natalizumab in multiple sclerosis.

Authors:  Abhijit Chaudhuri
Journal:  BMJ       Date:  2006-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.